Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 165

1.

Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation: From the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) and Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation (CONNECT AF).

Silberberg A, Tan MK, Yan AT, Angaran P, Dorian P, Bucci C, Gregoire JC, Bell AD, Gladstone DJ, Green MS, Gross PL, Skanes A, Demchuk AM, Kerr CR, Mitchell LB, Cox JL, Talajic M, Essebag V, Heilbron B, Ramanathan K, Fournier C, Wheeler BH, Lin PJ, Berall M, Langer A, Goldin L, Goodman SG; FREEDOM AF and CONNECT AF Investigators.

Am J Cardiol. 2017 Aug 15;120(4):582-587. doi: 10.1016/j.amjcard.2017.05.027. Epub 2017 Jun 1.

PMID:
28666577
2.

A unique form of a brady-tachy syndrome.

Ilhan E, Quinn FR, Exner DV, Mitchell LB, Veenhuyzen GD.

Pacing Clin Electrophysiol. 2017 Jul;40(7):894-896. doi: 10.1111/pace.13120. Epub 2017 Jun 30. No abstract available.

PMID:
28543039
3.

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.

Macle L, Cairns J, Leblanc K, Tsang T, Skanes A, Cox JL, Healey JS, Bell A, Pilote L, Andrade JG, Mitchell LB, Atzema C, Gladstone D, Sharma M, Verma S, Connolly S, Dorian P, Parkash R, Talajic M, Nattel S, Verma A; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2016 Oct;32(10):1170-1185. doi: 10.1016/j.cjca.2016.07.591. Epub 2016 Sep 6. Review. Erratum in: Can J Cardiol. 2017 Apr;33(4):552-553.

PMID:
27609430
4.

Molecular Differentiation of the African Yellow Fever Vector Aedes bromeliae (Diptera: Culicidae) from Its Sympatric Non-vector Sister Species, Aedes lilii.

Bennett KL, Linton YM, Shija F, Kaddumukasa M, Djouaka R, Misinzo G, Lutwama J, Huang YM, Mitchell LB, Richards M, Tossou E, Walton C.

PLoS Negl Trop Dis. 2015 Dec 7;9(12):e0004250. doi: 10.1371/journal.pntd.0004250. eCollection 2015 Dec.

5.

The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients.

Angaran P, Dorian P, Tan MK, Kerr CR, Green MS, Gladstone DJ, Mitchell LB, Fournier C, Cox JL, Talajic M, Lin PJ, Langer A, Goldin L, Goodman SG.

Can J Cardiol. 2016 Mar;32(3):336-43. doi: 10.1016/j.cjca.2015.07.012. Epub 2015 Oct 15.

PMID:
26476851
6.

The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines.

Macle L, Cairns JA, Andrade JG, Mitchell LB, Nattel S, Verma A; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2015 Oct;31(10):1207-18. doi: 10.1016/j.cjca.2015.06.005.

PMID:
26429352
7.

Sudden cardiac death.

Kuriachan VP, Sumner GL, Mitchell LB.

Curr Probl Cardiol. 2015 Apr;40(4):133-200. doi: 10.1016/j.cpcardiol.2015.01.002. Epub 2015 Feb 7. Review.

PMID:
25813838
8.

The new Canadian Cardiovascular Society algorithm for antithrombotic therapy of atrial fibrillation is appropriately based on current epidemiologic data.

Cairns JA, Healey JS, Macle L, Mitchell LB, Verma A; Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2015 Jan;31(1):20-3. doi: 10.1016/j.cjca.2014.11.021. Epub 2014 Nov 26. No abstract available.

PMID:
25547545
9.

2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.

Verma A, Cairns JA, Mitchell LB, Macle L, Stiell IG, Gladstone D, McMurtry MS, Connolly S, Cox JL, Dorian P, Ivers N, Leblanc K, Nattel S, Healey JS; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2014 Oct;30(10):1114-30. doi: 10.1016/j.cjca.2014.08.001. Epub 2014 Aug 13. Erratum in: Can J Cardiol. 2014 Dec;30(12):1495. Can J Cardiol. 2015 Oct;31(10):1302.

PMID:
25262857
10.

Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores.

Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB; APPROACH investigators.

Heart. 2014 Oct;100(19):1524-30. doi: 10.1136/heartjnl-2013-305303. Epub 2014 May 23.

PMID:
24860007
11.

Mosquitoes of eastern Amazonian Ecuador: biodiversity, bionomics and barcodes.

Linton YM, Pecor JE, Porter CH, Mitchell LB, Garzón-Moreno A, Foley DH, Pecor DB, Wilkerson RC.

Mem Inst Oswaldo Cruz. 2013;108 Suppl 1:100-9. doi: 10.1590/0074-0276130440.

12.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators.

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
14.

Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

Skanes AC, Healey JS, Cairns JA, Dorian P, Gillis AM, McMurtry MS, Mitchell LB, Verma A, Nattel S; Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2012 Mar-Apr;28(2):125-36. doi: 10.1016/j.cjca.2012.01.021. Erratum in: Can J Cardiol. 2012 May;28(3):396.

PMID:
22433576
15.

Diagnostic pacing maneuvers for supraventricular tachycardias: part 2.

Veenhuyzen GD, Quinn FR, Wilton SB, Clegg R, Mitchell LB.

Pacing Clin Electrophysiol. 2012 Jun;35(6):757-69. doi: 10.1111/j.1540-8159.2012.03352.x. Epub 2012 Mar 4.

PMID:
22385228
16.

Diagnostic pacing maneuvers for supraventricular tachycardia: part 1.

Veenhuyzen GD, Quinn FR, Wilton SB, Clegg R, Mitchell LB.

Pacing Clin Electrophysiol. 2011 Jun;34(6):767-82. doi: 10.1111/j.1540-8159.2011.03076.x. Epub 2011 Mar 25. Review.

PMID:
21438892
17.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery.

Mitchell LB; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):91-7. doi: 10.1016/j.cjca.2010.11.005.

PMID:
21329866
18.

Outcomes of after-hours versus regular working hours primary percutaneous coronary intervention for acute myocardial infarction.

Graham MM, Ghali WA, Southern DA, Traboulsi M, Knudtson ML; APPROACH Investigators.

BMJ Qual Saf. 2011 Jan;20(1):60-7. doi: 10.1136/bmjqs.2010.041137.

19.

Cardiac-resynchronization therapy for mild-to-moderate heart failure.

Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators.

N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540. Epub 2010 Nov 14.

20.

Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction.

Wilton SB, Fundytus A, Ghali WA, Veenhuyzen GD, Quinn FR, Mitchell LB, Hill MD, Faris P, Exner DV.

Am J Cardiol. 2010 Nov 1;106(9):1284-91. doi: 10.1016/j.amjcard.2010.06.053. Review.

PMID:
21029825

Supplemental Content

Loading ...
Support Center